.: ORİJİNAL ARAŞTIRMA
Complementary and Alternative Medicine Use in Pediatric Gastroenterology Outpatient Clinic: Cross-sectional Study
Pediatrik Gastroenteroloji Polikliniğinde Tamamlayıcı ve Alternatif Tıp Kullanımı: Kesitsel Çalışma
Turkiye Klinikleri J Pediatr. 2021;30(3):184-91
doi: 10.5336/pediatr.2021-84922
Makale Dili: EN
Tam Metin
Ücretsiz Erişim
ABSTRACT
Objective: Although there is sufficient data on the use of complementary and alternative medicine (CAM) in adults, the data on children is relatively limited. The present study was designed to investigate the frequency and factors associated with CAM usage in children with chronic liver and gastrointestinal diseases. Material and Methods: The study included patients aged 0-18 years who were followed up for chronic liver disease or gastrointestinal diseases. A questionnaire was administered to their parents, which probed information on the demographic characteristics and CAM use in children and the socioeconomic status and educational level of parents. Results: The study involved a total of 135 patients (60% girls, mean age of 10.45±5.05 years). Of these, 20 patients (14.8%) were found to be using CAM. The duration of CAM users' follow-up period was significantly higher than non-CAM user (5.84±3.71 years vs. 4.06±3.25 years, p=0.030). The frequency of CAM usage was significantly higher in patients with celiac disease (22.9%, p=0.049) and liver transplant recipients (44.4%, p=0.009). The frequency of CAM usage was significantly higher in patients who were not prescribed or were currently not using any conventional medicine compared to patients using conventional medicine (65% vs. 38.3%, odds ratio: 2.997). Conclusion: Although the frequency of CAM usage was low in our patient group, we consider that parents and physicians should be in full cooperation about the use of CAM and the effectiveness, side effects, toxicity, and potential drug interactions of CAM therapies.
Keywords: Complementary therapies; liver diseases; gastrointestinal diseases; child
Objective: Although there is sufficient data on the use of complementary and alternative medicine (CAM) in adults, the data on children is relatively limited. The present study was designed to investigate the frequency and factors associated with CAM usage in children with chronic liver and gastrointestinal diseases. Material and Methods: The study included patients aged 0-18 years who were followed up for chronic liver disease or gastrointestinal diseases. A questionnaire was administered to their parents, which probed information on the demographic characteristics and CAM use in children and the socioeconomic status and educational level of parents. Results: The study involved a total of 135 patients (60% girls, mean age of 10.45±5.05 years). Of these, 20 patients (14.8%) were found to be using CAM. The duration of CAM users' follow-up period was significantly higher than non-CAM user (5.84±3.71 years vs. 4.06±3.25 years, p=0.030). The frequency of CAM usage was significantly higher in patients with celiac disease (22.9%, p=0.049) and liver transplant recipients (44.4%, p=0.009). The frequency of CAM usage was significantly higher in patients who were not prescribed or were currently not using any conventional medicine compared to patients using conventional medicine (65% vs. 38.3%, odds ratio: 2.997). Conclusion: Although the frequency of CAM usage was low in our patient group, we consider that parents and physicians should be in full cooperation about the use of CAM and the effectiveness, side effects, toxicity, and potential drug interactions of CAM therapies.
Keywords: Complementary therapies; liver diseases; gastrointestinal diseases; child
ÖZET
Amaç: Erişkinlerde tamamlayıcı ve alternatif tıp (TAT) kullanımına ilişkin yeterli veri olmasına rağmen çocuklara ilişkin veriler kısıtlıdır. Bu çalışma, kronik karaciğer ve gastrointestinal hastalıkları olan çocuklarda TAT kullanımıyla ilişkili faktörleri ve sıklığını araştırmak için tasarlanmıştır. Gereç ve Yöntemler: Çalışmaya kronik karaciğer hastalığı veya gastrointestinal hastalık nedeniyle takip edilen 0-18 yaş arası hastalar alındı. Ebeveynlere, çocukların demografik özellikleri ve TAT kullanımı, ebeveynlerin sosyoekonomik durumu ve eğitim düzeyi hakkında bilgi veren bir anket uygulandı. Bulgular: Çalışmaya toplam 135 hasta dâhil edildi (%60 kız, ortalama yaş 10,45±5,05 yıl). Bunların 20'sinin (%14,8) TAT kullandığı tespit edildi. TAT kullanan hastaların takip süresi kullanmayan hastalara göre anlamlı olarak yüksekti (5,84±3,71 yıl vs. 4,06±3,25 yıl, p=0,030). TAT kullanım sıklığı çölyak hastalarında (%22,9, p=0,049) ve karaciğer nakli alıcılarında (%44,4, p=0,009) anlamlı olarak daha yüksekti. TAT kullanım sıklığı, konvansiyonel ilaç reçete edilmemiş olan veya hâlen herhangi bir konvansiyonel ilaç kullanmayan hastalarda, kullanan hastalara göre daha yüksekti (%65'e karşı %38,3; göreceli olasılıklar oranı: 2,997). Sonuç: Hasta grubumuzda TAT kullanım sıklığı düşük olmasına rağmen, TAT kullanımı ve TAT tedavilerinin etkinliği, yan etkileri, toksisitesi ve potansiyel ilaç etkileşimleri konusunda ebeveynler ve hekimlerin tam iş birliği içinde olması gerektiğini düşünüyoruz.
Anahtar Kelimeler: Tamamlayıcı tedaviler; karaciğer hastalıkları; gastrointestinal hastalıklar; çocuk
Amaç: Erişkinlerde tamamlayıcı ve alternatif tıp (TAT) kullanımına ilişkin yeterli veri olmasına rağmen çocuklara ilişkin veriler kısıtlıdır. Bu çalışma, kronik karaciğer ve gastrointestinal hastalıkları olan çocuklarda TAT kullanımıyla ilişkili faktörleri ve sıklığını araştırmak için tasarlanmıştır. Gereç ve Yöntemler: Çalışmaya kronik karaciğer hastalığı veya gastrointestinal hastalık nedeniyle takip edilen 0-18 yaş arası hastalar alındı. Ebeveynlere, çocukların demografik özellikleri ve TAT kullanımı, ebeveynlerin sosyoekonomik durumu ve eğitim düzeyi hakkında bilgi veren bir anket uygulandı. Bulgular: Çalışmaya toplam 135 hasta dâhil edildi (%60 kız, ortalama yaş 10,45±5,05 yıl). Bunların 20'sinin (%14,8) TAT kullandığı tespit edildi. TAT kullanan hastaların takip süresi kullanmayan hastalara göre anlamlı olarak yüksekti (5,84±3,71 yıl vs. 4,06±3,25 yıl, p=0,030). TAT kullanım sıklığı çölyak hastalarında (%22,9, p=0,049) ve karaciğer nakli alıcılarında (%44,4, p=0,009) anlamlı olarak daha yüksekti. TAT kullanım sıklığı, konvansiyonel ilaç reçete edilmemiş olan veya hâlen herhangi bir konvansiyonel ilaç kullanmayan hastalarda, kullanan hastalara göre daha yüksekti (%65'e karşı %38,3; göreceli olasılıklar oranı: 2,997). Sonuç: Hasta grubumuzda TAT kullanım sıklığı düşük olmasına rağmen, TAT kullanımı ve TAT tedavilerinin etkinliği, yan etkileri, toksisitesi ve potansiyel ilaç etkileşimleri konusunda ebeveynler ve hekimlerin tam iş birliği içinde olması gerektiğini düşünüyoruz.
Anahtar Kelimeler: Tamamlayıcı tedaviler; karaciğer hastalıkları; gastrointestinal hastalıklar; çocuk
REFERANSLAR:
- Shenfield G, Lim E, Allen H. Survey of the use of complementary medicines and therapies in children with asthma. J Paediatr Child Health. 2002;38(3):252-7. [Crossref] [PubMed]
- Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J Paediatr Child Health. 2005;41(1-2):23-6. [Crossref] [PubMed]
- Gottschling S, Gronwald B, Schmitt S, Schmitt C, Längler A, Leidig E, et al. Use of complementary and alternative medicine in healthy children and children with chronic medical conditions in Germany. Complement Ther Med. 2013;21 Suppl 1:S61-9. [Crossref] [PubMed]
- McCann LJ, Newell SJ. Survey of paediatric complementary and alternative medicine use in health and chronic illness. Arch Dis Child. 2006;91(2):173-4. [Crossref] [PubMed] [PMC]
- Black LI, Clarke TC, Barnes PM, Stussman BJ, Nahin RL. Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007-2012. Natl Health Stat Report. 2015;(78):1-19. [PubMed] [PMC]
- Orhan F, Sekerel BE, Kocabas CN, Sackesen C, Adalioglu G, Tuncer A. Complementary and alternative medicine in children with asthma. Ann Allergy Asthma Immunol. 2003;90(6):611-5. [Crossref] [PubMed]
- Demir N, Bilgiç A. A study determination of the effective factors beverage consumption expenditure of households in Turkey, SETSCI Conference Proceedings. 2019;4:208-14. [Crossref]
- Day AS. Use of complementary and alternative therapies and probiotic agents by children attending gastroenterology outpatient clinics. J Paediatr Child Health. 2002;38(4):343-6. [Crossref] [PubMed]
- Vlieger AM, Blink M, Tromp E, Benninga MA. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey. Pediatrics. 2008;122(2):e446-51. [Crossref] [PubMed]
- Adams D, Schiffgen M, Kundu A, Dagenais S, Clifford T, Baydala L, et al. Patterns of utilization of complementary and alternative medicine in 2 pediatric gastroenterology clinics. J Pediatr Gastroenterol Nutr. 2014;59(3):334-9. [Crossref] [PubMed]
- Philips CA, Augustine P, Rajesh S, Y PK, Madhu D. Complementary and alternative medicine-related drug-induced liver injury in Asia. J Clin Transl Hepatol. 2019;7(3):263-74. [PubMed] [PMC]
- Erlichman J, Salam A, Haber BA. Use of complementary and alternative medicine in pediatric chronic viral hepatitis. J Pediatr Gastroenterol Nutr. 2010;50(4):417-21. [Crossref] [PubMed]
- Liem KS, Yim C, Ying TD, Zanjir WR, Fung S, Wong DK, et al. Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B. Liver Int. 2019;39(8):1418-27. [Crossref] [PubMed]
- Akbulut UE, Çakır M. Fonksiyonel gastrointestinal problem olan çocuklarda tamamlayıcı ve alternatif tedavi kullanımı [Complementary and alternative medicine use in children with functional gastrointestinal problems]. Çocuk Sağlığı ve Hastalıkları Dergisi. 2015;58:17-22. [Link]
- Aziz I, Evans KE, Papageorgiou V, Sanders DS. Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? J Gastrointestin Liver Dis. 2011;20(1):27-31. [PubMed]
- Tickerhoof L, Wagener MM, Cacciarelli TV, Singh N. Alternative therapy use in liver transplant recipients. Prog Transplant. 2006;16(3):226-31. [Crossref] [PubMed]
- Fifi AC, Axelrod CH, Chakraborty P, Saps M. Herbs and spices in the treatment of functional gastrointestinal disorders: a review of clinical trials. nutrients. 2018;10(11):1715. [Crossref] [PubMed] [PMC]
- Karayağız Muslu G, Öztürk C. Tamamlayıcı ve alternatif tedaviler ve çocuklarda kullanımı [Complementary and alternative treatments and their practice in children]. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008;51:62-7. [Link]
- World Health Organization [Internet]. © WHO 2021. Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, et al. WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japan: WHO Centre for Health Development.(Erişim Tarihi: 02.03.2021) Available from: [Link]
- Shim JM. The influence of social context on the treatment outcomes of complementary and alternative medicine: the case of acupuncture and herbal medicine in Japan and the U.S. Global Health. 2015;11:17. [Crossref] [PubMed] [PMC]
- Araz N, Bulbul S. Use of complementary and alternative medicine in a pediatric population in southern Turkey. Clin Invest Med. 2011;34(1):E21-9. [Crossref] [PubMed]
- Ozturk C, Karayagiz G. Exploration of the use of complementary and alternative medicine among Turkish children. J Clin Nurs. 2008;17(19):2558-64. [Crossref] [PubMed]
- Francis A, Cho Y, Johnson DW. Honey in the prevention and treatment of infection in the CKD population: a narrative review. Evid Based Complement Alternat Med. 2015;2015:261425. [Crossref] [PubMed] [PMC]
- Akcay D, Yıldırımlar A. Çocuklarda tamamlayıcı ve alternatif tedavi kullanımı ve ebeveyn bilgilerinin değerlendirilmesi [Use of complementary and alternative therapy in children and evaluation of parental information]. Journal of the Child. 2017;17:174-81. [Crossref]
- Taşar MA, Potur ED, Kara N, Bostancı İ, Dallar Y. Düşük gelir düzeyine sahip ailelerin çocuklarına tamamlayıcı veya alternatif tıp uygulamaları: Ankara Hastanesi verileri [The complementary or alternative medicine practices in children of low-income families: data of Ankara Hospital]. Turkish J Pediatr Dis. 2011;5(2):81-8. [Link]
- Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002;97(2):382-8. [Crossref] [PubMed]
- Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: a systemic review and case-control study. Medicine (Baltimore). 2019;98(13):e14992. [Crossref] [PubMed] [PMC]
- Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006;6:19. [Crossref] [PubMed] [PMC]
- Gerasimidis K, McGrogan P, Hassan K, Edwards CA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27(2):155-65. [Crossref] [PubMed]
.: İşlem Listesi